Bridgeway Capital Management, LLC Oncocyte Corp Transaction History

Bridgeway Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.15 - $2.25 $236,094 - $461,925	205,300 New	205,300 $306,000
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $371,709 - $620,217	-105,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.77 - $6.0 $358,150 - $570,000	-95,000 Reduced 47.43%	105,300 $604,000
Q1 2021 May 17, 2021	SELL	$2.39 - $6.5 $131,450 - $357,500	-55,000 Reduced 21.54%	200,300 $1.04 Million
Q3 2020 Nov 16, 2020	BUY	$1.2 - $1.89 $120,000 - $189,000	100,000 Added 64.39%	255,300 $355,000
Q2 2020 Aug 14, 2020	SELL	$1.91 - $3.45 $143,250 - $258,750	-75,000 Reduced 32.57%	155,300 $297,000
Q4 2019 Feb 14, 2020	SELL	$1.51 - $2.27 $60,400 - $90,800	-40,000 Reduced 14.8%	230,300 $518,000
Q3 2019 Nov 14, 2019	BUY	$1.59 - $2.51 $159,000 - $250,999	100,000 Added 58.72%	270,300 $568,000
Q2 2019 Aug 14, 2019	SELL	$2.49 - $5.45 $61,503 - $134,615	-24,700 Reduced 12.67%	170,300 $424,000
Q4 2018 Feb 14, 2019	SELL	$1.38 - $2.59 $144,900 - $271,950	-105,000 Reduced 35.0%	195,000 $269,000
Q2 2018 Aug 14, 2018	BUY	$2.0 - $3.3 $370,000 - $610,500	185,000 Added 160.87%	300,000 $765,000
Q1 2018 May 15, 2018	SELL	$1.25 - $4.6 $37,500 - $138,000	-30,000 Reduced 20.69%	115,000 $242,000
Q3 2017 Nov 14, 2017	BUY	$4.55 - $7.55 $659,750 - $1.09 Million	145,000	145,000 $1.1 Million

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.